Substrates for peptidase S01.017: kallikrein-related peptidase 5
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antileukoproteinase | P03973 | 26-132 | peptide-Arg45+Tyr-peptide | P | NT | Gln | Cys | Leu | Arg | Tyr | Lys | Lys | Pro | Borgoņo et al., 2007 | ||
| cathelicidin antimicrobial peptide | P49913 | 134-170 | peptide-Arg140+Lys-peptide | P | Asp | Phe | Phe | Arg | Lys | Ser | Lys | Glu | Yamasaki et al., 2006 | 22745 | ||
| cathelicidin antimicrobial peptide | P49913 | 134-170 | peptide-Arg152+Ile-peptide | P | Glu | Phe | Lys | Arg | Ile | Val | Gln | Arg | Yamasaki et al., 2006 | 22746 | ||
| cathelicidin antimicrobial peptide | P49913 | 134-170 | peptide-Arg156+Ile-peptide | P | Ile | Val | Gln | Arg | Ile | Lys | Asp | Phe | Yamasaki et al., 2006 | 22747 | ||
| cathelicidin antimicrobial peptide | P49913 | 134-170 | peptide-Arg162+Asn-peptide | P | Asp | Phe | Leu | Arg | Asn | Leu | Val | Pro | Yamasaki et al., 2006 | 22748 | ||
| cathelicidin antimicrobial peptide | P49913 | 134-170 | peptide-Arg167+Thr-peptide | P | Leu | Val | Pro | Arg | Thr | Glu | Ser | Gly | Yamasaki et al., 2006 | 22749 | ||
| Cathelicidin antimicrobial peptide | P49913 | 1-170 | peptide-Ala133+Leu-peptide | P | Lys | Arg | Phe | Ala | Leu | Leu | Gly | Asp | Yamasaki et al., 2006 | |||
| Desmoglein-1 | Q02413 | 50-1049 | peptide-Arg242+Asp-peptide | P | NT | Gly | Ser | Asp | Arg | Asp | Gly | Gly | Ala | Borgoņo et al., 2007 | ||
| Desmoglein-1 | Q02413 | 50-1049 | peptide-Arg422+Tyr-peptide | P | NT | Thr | Thr | Val | Arg | Tyr | Val | Met | Gly | Borgoņo et al., 2007 | ||
| Desmoglein-1 | Q02413 | 50-1049 | peptide-Arg146+Val-peptide | P | NT | Leu | Arg | Val | Arg | Val | Leu | Asp | Ile | Borgoņo et al., 2007 | ||
| Fibrinogen alpha chain | P02671 | 20-866 | peptide-Arg367+Gly-peptide | P | NT | Ser | Ser | Glu | Arg | Gly | Ser | Ala | Gly | Michael et al., 2005 | ||
| Fibrinogen alpha chain | P02671 | 20-866 | peptide-Arg426+Glu-peptide | P | NT | Gly | Thr | Arg | Arg | Glu | Tyr | His | Thr | Michael et al., 2005 | ||
| fibrinogen beta chain | P02675 | 31-491 | peptide-Arg44+Gly-peptide | P | Phe | Ser | Ala | Arg | Gly | His | Arg | Pro | Michael et al., 2005 | |||
| Fibrinogen beta chain | P02675 | 31-491 | peptide-Lys83+Lys-peptide | P | NT | Ala | Thr | Gln | Lys | Lys | Val | Glu | Arg | Michael et al., 2005 | ||
| hepatocyte growth factor activator | Q04756 | 373-655 | peptide-Arg407+Ile-peptide | P | Leu | Arg | Pro | Arg | Ile | Ile | Gly | Gly | Mukai et al., 2008 | 20893 | ||
| Insulin-like growth factor-binding protein 1 | P08833 | 26-259 | peptide-Lys162+Ala-peptide | P | NT | Asp | Gly | Ser | Lys | Ala | Leu | His | Val | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 1 | P08833 | 1-259 | peptide-Gly25+Ala-peptide | P | NT | Val | Thr | Ala | Gly | Ala | Pro | Trp | Gln | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 2 | P18065 | 1-325 | peptide-Arg35+Gln-peptide | P | NT | Gly | Gly | Ala | Arg | Ala | Glu | Val | Leu | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 2 | P18065 | 36-325 | peptide-Arg200+Gln-peptide | P | NT | Glu | Gln | His | Arg | Gln | Met | Gly | Lys | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 3 | P17936 | 28-291 | peptide-Arg185+Tyr-peptide | P | NT | Asp | Ser | Gln | Arg | Tyr | Lys | Val | Asp | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 3 | P17936 | 28-291 | peptide-Arg233+Gly-peptide | P | NT | Leu | Ser | Pro | Arg | Gly | Val | His | Ile | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 3 precursor | P17936 | 1-291 | peptide-Ala27+Gly-peptide | P | NT | Val | Ala | Arg | Ala | Gly | Ala | Ser | Ser | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 4 | P22692 | 22-258 | peptide-Arg191+Thr-peptide | P | NT | Ser | Gln | Ser | Arg | Thr | His | Glu | Asp | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 4 precursor | P22692 | 1-258 | peptide-Gly21+Asp-peptide | P | NT | Pro | Ser | Leu | Gly | Asp | Glu | Ala | Ile | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 5 | P24593 | 21-272 | peptide-Cys27+Glu-peptide | P | NT | Phe | Val | His | Cys | Glu | Pro | Cys | Asp | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 5 | P24593 | 21-272 | peptide-Arg143+Ile-peptide | P | NT | Lys | His | Thr | Arg | Ile | Ser | Glu | Leu | Michael et al., 2006 | ||
| Insulin-like growth factor-binding protein 5 | P24593 | 21-272 | peptide-Arg212+Ala-peptide | P | NT | Met | Val | Pro | Arg | Ala | Val | Tyr | Leu | Michael et al., 2006 | ||
| Kallikrein-1 | P06870 | 21-27 | peptide-Arg24+Ile-Val-Gly | N | Ile | Gln | Ser | Arg | Ile | Val | Gly | - | Michael et al., 2006 | |||
| Kallikrein-1 precursor | P06870 | 19-262 | peptide-Arg24+Ile-peptide | P | NT | Ile | Gln | Ser | Arg | Ile | Val | Gly | Gly | Yoon et al., 2007 | ||
| Kallikrein-10 precursor | O43240 | 31-276 | peptide-Arg42+Leu-peptide | P | NT | Asn | Asp | Thr | Arg | Leu | Asp | Pro | Glu | Yoon et al., 2007 | ||
| Kallikrein-11 | Q9UBX7 | 31-36 | Glu-Thr-Arg+Ile-Ile-Lys | N | - | Glu | Thr | Arg | Ile | Ile | Lys | - | Michael et al., 2006 | |||
| Kallikrein-12 | Q9UKR0-1 | 15-21 | peptide-Lys21+Ile-peptide | N | Ala | Thr | Pro | Lys | Ile | Phe | Asn | - | Michael et al., 2006 | |||
| Kallikrein-13 precursor | Q9UKR3 | 17-277 | peptide-Lys25+Val-peptide | P | NT | Glu | Ser | Ser | Lys | Val | Leu | Asn | Thr | Yoon et al., 2007 | ||
| Kallikrein-15 | Q9H2R5-2 | 18-24 | peptide-Lys21+Leu-peptide | N | Asp | Gly | Asp | Lys | Leu | Leu | Glu | - | Michael et al., 2006 | |||
| Kallikrein-15 precursor | Q9H2R5 | 17-256 | peptide-Lys21+Leu-peptide | P | NT | Asp | Gly | Asp | Lys | Leu | Leu | Glu | Gly | Yoon et al., 2007 | ||
| Kallikrein-2 precursor | P20151 | 19-261 | peptide-Arg24+Ile-peptide | P | NT | Ile | Gln | Ser | Arg | Ile | Val | Gly | Gly | Michael et al., 2006 | ||
| Kallikrein-8 | O60259 | 29-35 | peptide-Lys32+Val-peptide | N | Gln | Glu | Asp | Lys | Val | Leu | Gly | - | Michael et al., 2006 | |||
| Kallikrein-8 precursor | O60259 | 29-260 | Gln-Glu-Asp-Lys32+Val-peptide | P | NT | Gln | Glu | Asp | Lys | Val | Leu | Gly | Gly | Yoon et al., 2007 | ||
| Kallikrein-9 | Q9UKQ9 | 19-25 | peptide-Arg22+Ala-peptide | N | Ala | Asp | Thr | Arg | Ala | Ile | Gly | - | Michael et al., 2006 | |||
| Kallikrein-9 precursor | Q9UKQ9 | 16-250 | peptide-Arg22+Ala-peptide | P | NT | Ala | Asp | Thr | Arg | Ala | Ile | Gly | Ala | Yoon et al., 2007 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 19-251 | peptide-Lys40+Ile-peptide | P | Asp | Glu | Asn | Lys | Ile | Ile | Gly | Gly | Brattsand et al., 2005 | 21058 | ||
| kallikrein-related peptidase 5 | Q9Y337 | 23-293 | peptide-Arg66+Ile-peptide | P | Ser | Ser | Ser | Arg | Ile | Ile | Asn | Gly | Brattsand et al., 2005 | 21055 | ||
| kallikrein-related peptidase 7 | P49862 | 23-253 | peptide-Lys29+Ile-peptide | P | Gln | Gly | Asp | Lys | Ile | Ile | Asp | Gly | Brattsand et al., 2005 | 21056 | ||
| Kininogen-1 | P01042 | 19-644 | peptide-Arg240+Ile-peptide | P | NT | Ile | Gln | Leu | Arg | Ile | Ala | Ser | Phe | Michael et al., 2005 | ||
| Kininogen-1 | P01042 | 19-644 | peptide-Arg269+Asp-peptide | P | NT | Gly | Cys | Pro | Arg | Asp | Ile | Pro | Thr | Michael et al., 2005 | ||
| Kininogen-1 | P01042 | 19-644 | peptide-Arg392+Ile-peptide | P | NT | Arg | Ser | Ser | Arg | Ile | Gly | Glu | Ile | Michael et al., 2005 | ||
| Meprin A subunit alpha precursor | Q16819 | 1-746 | Peptide-Arg65+Asn-Peptide | P | - | Gln | Lys | Ser | Arg | Asn | Gly | Leu | Arg | Debela et al., 2008 | ||
| Meprin A subunit beta | Q16820 | 1-701 | Peptide-Arg61+Asn-Peptide | P | - | Ala | Gln | Ile | Arg | Asn | Ser | Ile | Ile | Debela et al., 2008 | ||
| Plasminogen | P00747 | 20-810 | peptide-Lys96+Lys-peptide | P | NT | Leu | Phe | Glu | Lys | Lys | Val | Tyr | Leu | Michael et al., 2005 | ||
| Plasminogen | P00747 | 20-810 | peptide-Arg549+Lys-peptide | P | NT | Thr | Asn | Pro | Arg | Lys | Leu | Tyr | Asp | Michael et al., 2005 | ||
| Prostate-specific antigen | P07288 | 25-261 | peptide-Arg109+Phe-peptide | P | NT | Leu | Lys | Asn | Arg | Phe | Leu | Arg | Pro | Michael et al., 2006 | ||
| Prostate-specific antigen | P07288 | 25-261 | peptide-Lys206+Ser-peptide | P | NT | Thr | Gly | Gly | Lys | Ser | Thr | Cys | Ser | Michael et al., 2006 | ||
| Prostate-specific antigen precursor | P07288 | 18-261 | peptide-Lys169+Lys-peptide | P | NT | Leu | Thr | Pro | Lys | Lys | Leu | Gln | Cys | Debela et al., 2008 | ||
| Prostate-specific antigen precursor | P07288 | 18-261 | peptide-Arg24+Ile-peptide | P | NT | Ile | Leu | Ser | Arg | Ile | Val | Gly | Gly | Michael et al., 2006 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Arg41+Ser-peptide | P | MS | Leu | Asp | Pro | Arg | Ser | Phe | Leu | Leu | Oikonomopoulou et al., 2006 | 20607 | |
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Phe43+Leu-peptide | P | MS | Pro | Arg | Ser | Phe | Leu | Leu | Arg | Asn | Oikonomopoulou et al., 2006 | 20608 | |
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Arg29+Ser-peptide | P | MS | Gly | Thr | Asn | Arg | Ser | Ser | Lys | Gly | Oikonomopoulou et al., 2006 | 20616 | |
| proteinase-activated receptor 2 | Q63645 | 26-397 | peptide-Lys34+Gly-peptide | P | MS | Pro | Asn | Ser | Lys | Gly | Arg | Ser | Leu | Oikonomopoulou et al., 2006 | 20643 | |
| proteinase-activated receptor 2 | Q63645 | 26-397 | peptide-Arg36+Ser-peptide | P | MS | Ser | Lys | Gly | Arg | Ser | Leu | Ile | Gly | Oikonomopoulou et al., 2006 | ||
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Arg47+Gly-peptide | P | MS | Pro | Ala | Pro | Arg | Gly | Tyr | Pro | Gly | Oikonomopoulou et al., 2006 | 20621 | |
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Gly51+Gln-peptide | P | MS | Gly | Tyr | Pro | Gly | Gln | Val | Cys | Ala | Oikonomopoulou et al., 2006 | 20622 | |
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Gly35+Asp-peptide | P | MS | Thr | Gly | Gly | Gly | Asp | Asp | Ser | Thr | Oikonomopoulou et al., 2006 | 20623 | |
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Asp36+Asp-peptide | P | MS | Gly | Gly | Gly | Asp | Asp | Ser | Thr | Pro | Oikonomopoulou et al., 2006 | 20624 | |
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Asp37+Ser-peptide | P | MS | Gly | Gly | Asp | Asp | Ser | Thr | Pro | Ser | Oikonomopoulou et al., 2006 | 20625 | |
| proteinase-activated receptor 4 precursor | Q920E0 | 17-395 | peptide-Arg49+Gly-peptide | P | MS | Pro | Asn | Pro | Arg | Gly | Phe | Pro | Gly | Oikonomopoulou et al., 2006 | 20641 | |
| proteinase-activated receptor 4 precursor | Q920E0 | 17-395 | peptide-Gly50+Phe-peptide | P | MS | Asn | Pro | Arg | Gly | Phe | Pro | Gly | Lys | Oikonomopoulou et al., 2006 | 20642 | |
| S-2222 | Bz-Ile-Glu-Gly-Arg+NHPhNO2 | S | Ile | Glu | Gly | Arg | NAN | - | - | - | Brattsand et al., 2005 | |||||
| S-2288 | D-Ile-Pro-Arg+NHPhNO2 | S | - | DIl | Pro | Arg | NAN | - | - | - | Brattsand et al., 2005 | |||||
| S-2302 | D-Pro-Phe-Arg+NHPhNO2 | S | - | DPr | Phe | Arg | NAN | - | - | - | Brattsand et al., 2005 | |||||
| Somatotropin | P01241 | 27-217 | Peptide-Arg34+Leu-Peptide | P | NT | Pro | Leu | Ser | Arg | Leu | Phe | Asp | Asn | Komatsu et al., 2007 | ||
| Somatotropin | P01241 | 27-217 | Peptide-Arg120+Ser-Peptide | P | NT | Gln | Phe | Leu | Arg | Ser | Val | Phe | Ala | Komatsu et al., 2007 | ||
| Urokinase-type plasminogen activator | P00749 | 21-431 | Peptide-Lys178+Ile-Peptide | P | - | Pro | Arg | Phe | Lys | Ile | Ile | Gly | Gly | Debela et al., 2008 | ||
| Vitronectin | P04004 | 20-478 | peptide-Arg27+Cys-peptide | P | NT | Cys | Lys | Gly | Arg | Cys | Thr | Glu | Gly | Michael et al., 2005 | ||
| Z-Leu-Arg-NHMec | Z-Leu-Arg+NHMec | S | - | Z | Leu | Arg | AMC | - | - | - | Debela et al., 2006 | |||||
| Z-Phe-Arg-NHMec | Z-Phe-Arg-NHMec | S | - | Z | Phe | Arg | AMC | - | - | - | Debela et al., 2006 |
